Growing a circular economy with fungal biotechnology: a white paper. by Meyer, Vera et al.
Meyer et al. Fungal Biol Biotechnol             (2020) 7:5  
https://doi.org/10.1186/s40694-020-00095-z
REVIEW
Growing a circular economy with fungal 
biotechnology: a white paper
Vera Meyer1* , Evelina Y. Basenko2 , J. Philipp Benz3 , Gerhard H. Braus4 , Mark X. Caddick2 ,  
Michael Csukai5 , Ronald P. de Vries6 , Drew Endy7 , Jens C. Frisvad8 , Nina Gunde‑Cimerman9 ,  
Thomas Haarmann10 , Yitzhak Hadar11 , Kim Hansen12 , Robert I. Johnson13, Nancy P. Keller14 , 
Nada Kraševec15 , Uffe H. Mortensen8 , Rolando Perez7, Arthur F. J. Ram16 , Eric Record17 , Phil Ross18, 
Volha Shapaval19 , Charlotte Steiniger1 , Hans van den Brink20, Jolanda van Munster21 , Oded Yarden11  
and Han A. B. Wösten22 
Abstract 
Fungi have the ability to transform organic materials into a rich and diverse set of useful products and provide distinct 
opportunities for tackling the urgent challenges before all humans. Fungal biotechnology can advance the transition 
from our petroleum‑based economy into a bio‑based circular economy and has the ability to sustainably produce 
resilient sources of food, feed, chemicals, fuels, textiles, and materials for construction, automotive and transportation 
industries, for furniture and beyond. Fungal biotechnology offers solutions for securing, stabilizing and enhancing the 
food supply for a growing human population, while simultaneously lowering greenhouse gas emissions. Fungal bio‑
technology has, thus, the potential to make a significant contribution to climate change mitigation and meeting the 
United Nation’s sustainable development goals through the rational improvement of new and established fungal cell 
factories. The White Paper presented here is the result of the 2nd Think Tank meeting held by the EUROFUNG consor‑
tium in Berlin in October 2019. This paper highlights discussions on current opportunities and research challenges in 
fungal biotechnology and aims to inform scientists, educators, the general public, industrial stakeholders and policy‑
makers about the current fungal biotech revolution.
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Introduction
The term ‘biotechnology’ was coined by the Hungarian 
Karl Ereky [1] in 1919, the same year that Pfizer became 
the first company to commercialise a product manufac-
tured by the controlled fermentation of a mould. The 
product Pfizer made was citric acid for commercial use 
as a flavouring agent, acidifier and chelating agent in 
food, beverages, and the pharma and chemical indus-
tries. It was produced biotechnologically with the mould 
Aspergillus niger [2], and 100 years later, citric acid is still 
produced with this filamentous fungus and has formed 
a fast growing multibillion Euro market for convenience 
foods and beverages [2, 3]. Many organic acids, enzymes, 
life-saving antibiotics and drugs are produced by filamen-
tous fungi, and a lot of our foods and beverages would 
not exist at all without their fermentative capacities [4]. 
It is undisputed that filamentous fungal-based biotech-
nology is of pivotal importance to our daily lives. Many 
companies around the globe are leveraging the power 
of filamentous fungi, with major players in Europe that 
include: AB Enzymes, BASF, Bayer, Chr. Hansen, Dyadic 
International, DSM, DuPont, Kerry Group, Marlow 
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In a more recent endeavour, biologists, chemists, bio-
informaticians, bioengineers, process engineers and 
material scientists have collaborated to turn by-products 
and waste from agriculture and forestry into composite 
materials with the help of mushroom-forming fungi. The 
vision offered by this group is disruptive: soon, we will sit 
on mushroom-created furniture, we will live in houses 
made from fungal hyphae, plastics and insulation mate-
rials in cars, trains, planes and spacecrafts will be com-
posed of fungal composites and many of our textiles will 
be derived from fungi. In the not so distant future, new 
fungal-based products will be introduced into the market 
that offer similar or superior characteristics compared to 
classic petroleum-derived products, with a reduced or 
even negative carbon footprint and full biodegradabil-
ity. Another vision is not so far-fetched at all: products 
made with animal leather will be superseded in qual-
ity and price by those made with pure fungal mycelium. 
Such replacements will have substantial implications for 
the livestock, textile and fashion industries.
Fungi growing as a yeast morphology have impacted 
society for millennia and have been instrumental for the 
production of bread, beer and wine. However, fungal 
species capable of the filamentous growth form, which 
are the focus of this White Paper, have additional ben-
eficial properties such as the productions of a diverse 
array of metabolites, enzymes and materials. Indeed, 
Scientific American stated in 2019 that: “The mycelium 
revolution is upon us” [5]. A 100 years after the birth of 
fungal biotechnology, this platform technology is under-
going a renaissance by providing sustainable solutions for 
diverse industries and markets [6]. In the following, we 
will summarize current and anticipated products made 
from moulds and mushrooms and related new avenues 
of research. We will also highlight recommendations 
discussed during the EUROFUNG 2nd Think Tank con-
sortium for ways to drive innovation in this renaissance 
through strategic and infrastructural measures for basic 
and applied science on filamentous fungi.
The lifestyle of filamentous fungi—moulds 
and mushrooms
The life of a filamentous fungus usually starts with a 
spore, which has a diameter of only a few microns (µm) 
(Fig. 1). The spore starts to swell in a humid and nutri-
ent-rich environment and germinates. A germ tube is 
formed that elongates to eventually form a thread-
like, filamentous cell, called a hypha. After the hypha 
grows and elongates for some time, it forms a net-
work of interconnected hyphal threads called a myce-
lium. When nutrients become limited in the substrate 
within which the mycelium lives, the mycelium starts to 
explore the air and space in order to form reproductive 
structures. Ascomycetes (moulds) can form conidi-
ophores that produce asexual spores at their ends and/
or fruiting bodies that produce sexual spores inside 
them. Basidiomycetes are known for their ability to 
form fruiting bodies to generate sexual spores. Some 
of these fruiting bodies are colloquially called mush-
rooms. These fruiting bodies consist of mycelia which 
are more densely packed and different in their com-
position compared to the rather loose substrate myce-
lia, which forms three-dimensional net-like structures 
resembling the global system of interconnected com-
puter networks.
Filamentous fungi are both invisible and visible. The 
diameter of fungal hyphae range from 2 to 10  µm, and 
a fungal mycelium consists of a network of mm- to cm-
long hypha. The mycelia of mushroom-forming fungi 
can colonise large surface areas, as illustrated by an indi-
vidual of the honey mushroom Armillaria bulbosa (com-
mon name honey mushroom in English and Hallimasch 
in German) which has colonised > 1000 hectares of forest 
soil, making it the largest and oldest organism on Earth 
[7]. Mycelia of mushroom-forming fungi can also be 
grown on various by-products and waste streams from 
forestry and agriculture. The efficiency of colonisation 
and biomass formation is determined by the composi-
tion and physical properties of the substrate, the environ-
mental growth conditions (temperature, humidity and 
pH) and the genetic make-up of the fungus. A strain of 
Schizophyllum commune (common name split gill), for 
instance, in which two regulatory genes for mushroom 
formation are inactivated, produces threefold more bio-
mass of fungal tissue when compared to the parental 
strain [8].
Filamentous fungi have evolved to become superbly 
efficient decomposers and have developed the ability to 
feed on and break down organic matter and polymeric 
substances [9]. Polysaccharides from plant biomass 
make up most of the biomass on Earth (450 out of a 
total of 550 gigatons of carbon; [10]) and represent 
the major carbon sources that drives fungal growth. 
In order to digest, humans must first ingest. Filamen-
tous fungi first digest and then ingest. The fungal cells 
that infiltrate a substrate secrete enzymes, such as cel-
lulases, amylases, pectinases, inulases, proteases and 
lipases, into the surrounding medium and hydrolyse 
(break down) plant polysaccharides (e.g. cellulose, 
starch, pectin, inulin), proteins and lipids. The degra-
dation products of polysaccharides are monosaccha-
rides, such as glucose, and oligosaccharides, which are 
subsequently taken up into the hyphae with the help 
of specific sugar transporters. This hydrolytic capac-
ity for plant biomass, coupled with an extraordinary 
high secretion capacity for enzymes (up to 100 g/L are 
Page 3 of 23Meyer et al. Fungal Biol Biotechnol             (2020) 7:5  
reported; [11]), forms the basis for the success of high-
performance enzyme-producing cell factories, such as 
A. niger, A. oryzae, Trichoderma reesei and Thermoth-
elomyces thermophilus (all being ascomycetes). Their 
enzyme products are exploited by a diverse array of 
major industries, including food and feed, detergent, 
pulp and paper, fuel, pharmaceutical and chemical 
(Fig. 2; [4]).
Notably, the predicted gene set for plant polysaccha-
ride-degrading enzymes in these fungi is between 100 
and 250, whereas only 30 can be found in the baker’s 
yeast Saccharomyces cerevisiae. The success of S. cerevi-
siae, which cannot grow on plant polymeric substances 
[12], or the bacterium Escherichia coli as platform 
organisms to produce biofuel (ethanol), jet fuel (terpe-
noids), fine and commodity chemicals is only guaran-
teed by the filamentous fungal cell factories mentioned 
above that provide S. cerevisiae and E. coli with sim-
ple carbon sources during the fermentation process. 
Hence, filamentous fungal cell factories play a cen-
tral role in the sustainable production of biofuels and 
chemicals.
The product portfolio of filamentous fungi—an overview
The product range of filamentous fungi is not limited 
to citric acid and enzymes (Table 1). In fact, the natural 
metabolic capacities of filamentous fungi are extraordi-
narily diverse and unmatched in nature. Organic acids, 
Fig. 1 The fungal life cycle
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chemicals, antibiotics and other drugs, proteins and 
enzymes, meat alternatives, vitamins, polyunsaturated 
fatty acids and even composite materials and vegan leath-
ers are existing fungal products. Table 2 highlights some 
currently traded pharmaceuticals derived from filamen-
tous fungi.
Note that T. thermophilus was formerly named Myceli-
ophthora thermophila and that the P. chrysogenum strain 
used for penicillin production was recently reidentified 
as P. rubens [14, 15]. While this review focuses on the 
Dikarya lineage, that is the ascomycetes and basidiomy-
cetes, five species in this list are found in another lineage, 
the Mucoromycota.
Some examples of current developments with fungal 
cell factories that will help to consolidate bio-economies 
and human health are summarized as follows.
Aspergillus niger is currently being explored by aca-
demia as a potential producer of other organic acids 
Fig. 2 Industries profiting from the metabolic capacities of filamentous fungi
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beyond citric acid, such as itaconate and galactarate. Ita-
conate could replace petroleum-based polyacrylic acid, 
which is a precursor for the polymer industry (absor-
bent polymers, polyester resins, synthetic latex) and 
galactarate could replace the current petroleum-based 
polyethylene terephthalate (PET) used for plastic produc-
tion [17, 18].
A. oryzae, used to produce Asian food and beverages 
for over a 1000 years, has recently gained interest as a 
producer of malate, which has multiple applications in 
the food (acidulant, flavour enhancer), chemical (poly-
ester resins) and pharmaceutical (acidulant) industries 
Table 1 Selected list of established filamentous fungal cell factories and their products. (Modified after [13])
Filamentous fungus Important Product(s)
Acremonium chrysogenum β‑lactam antibiotics (cephalosporins)
Aspergillus niger Enzymes (glucoamylase, proteases, phytases, glucose oxidase)
Organic acids (citric acid, gluconic acid)
Aspergillus oryzae Enzymes (amylases)
Aspergillus terreus Enzymes (xylanases)
Organic acids (itaconic acid)
Secondary metabolites (lovastatin)
Blakeslea trispora Vitamins (β‑carotene)
Fusarium venenatum Mycoprotein as meat alternative
Ganoderma lucidum Composite materials (packaging material, construction material)
Imitation leather
Mortierella alpina Polyunsaturated fatty acids used as food additives
Mucor circinelloides Polyunsaturated fatty acids used as food additives
Penicillium brevicompactum Mycophenolic acid
Penicillium camemberti Cheese production
Penicillium chrysogenum β‑lactam antibiotics (penicillins)
Enzymes (glucose oxidase)
Penicillium nalgiovense Mould‑fermented salami
Penicillium roqueforti Cheese production
Penicillium solitum Mevastatin
Pleurotus ostreatus Food
Composite materials (packaging material, construction material)
Rhizopus oligosporus Tempeh production
Thermothelomyces thermophilus Enzymes (cellulases, phytases, laccases)
Trichoderma reesei Enzymes (cellulases, hemicellulases)
Umbelopsis isabellina Polyunsaturated fatty acids used as biodiesel
Table 2 Selected pharmaceuticals derived from filamentous fungi and their applications. (Modified after [13])
Pharmaceutical Remark
β‑lactams Penicillins and cephalosporins account for more than 30% of the global antibiotics market
Cyclosporin Immunosuppressant that avoids organ rejection in transplant surgery
Drospirenone Steroid hormone used as a birth control pill and traded as Slynd; in combination with an oestrogen traded 
under the brand name Yasmin
Echinocandins Caspofungin, micafungin and anidulafungin used for the treatment of Candida infections
Griseofulvin Antifungal used for the treatment of skin infections
Mycophenolic acid Immunosuppressant that avoids organ rejection in transplant surgery and is traded as CellCept
Myriocin Chemical analogue thereof is used to treat multiple sclerosis; approved in 2018 as Gilenya
Psilocybin Indolalkaloid currently being tested in phase II clinical trials for the treatment of major depressive disorders 
and is considered by the FDA as a breakthrough therapy [16]
Statins Lovastatin, simvastatin and pravastatin are used to treat cardiovascular diseases by lowering cholesterol levels
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[19]. While several microbial cell factories from bacte-
rial, yeast or filamentous fungal origin have been genet-
ically engineered during the last few years to produce 
malate, A. oryzae is among the strains with the greatest 
yields [20].
A. terreus is exploited as a cell factory to produce two 
molecules: the organic acid itaconate, which is of interest 
for the polymer industry [21], and lovastatin, which is a 
cholesterol-lowering drug. Lovastatin has been marketed 
under the tradename Mevacor since the late 1980 s [22]. 
It, furthermore, serves as a starter molecule for manufac-
turing semisynthetic statins, such as simvastatin (trade 
name Zocor), which is the second leading statin on the 
market [23]. Current research is focused on re-routing 
lovastatin biosynthesis to one of its biosynthetic interme-
diates, monacolin J, which is the preferred precursor for 
Zocor synthesis [24]. Notably, a genetically engineered 
A. oryzae strain can reach monacolin J concentrations 
of about 5.5  g/L, which is considerably higher than has 
been achieved in heterologous hosts, such as S. cerevi-
siae (75 mg/L) or Pichia pastoris (renamed Komagataella 
phaffii; 600 mg/L) [25].
P. chrysogenum (P. rubens) is an antibiotics producer 
and the main cell factory used to produce penicillin and 
semisynthetic derivatives, with production levels up to 
55  g/L [26]. Notably, the biosynthetic route for penicil-
lin has recently been genetically reprogrammed towards 
pravastatin, which constitutes an interesting alternative 
to Zocor for the pharma industry [27].
T. reesei and T. thermophilus (formally Myceliophthora 
thermophila) are of commercial interest because of their 
ability to secrete cellulases and hemicellulases. These 
enzymes are key to converting lignocellulosic biomass 
into biofuel. Lignocellulose is composed of cellulose, 
hemicellulose and lignin and is a by-product of agricul-
ture (e.g. straw, bagasse, corn stover) and forestry (e.g. 
sawdust). The thermostability of (hemi)cellulases from T. 
thermophilus are of special interest for current lignocel-
lulose degradation processes, as high process tempera-
tures are preferred in biorefineries to reduce the viscosity 
and increase the solubility of lignocellulosic biomass [28]. 
Genetically optimised hypersecreting strains have been 
established during the last two decades which achieve 
cellulase titres of 100  g/L [11]. These are the highest 
titres ever reported for protein secretion and exceed by 
10–10,000-fold what can be achieved nowadays with bac-
terial, yeast or mammalian cell factories. Protein secre-
tion titres in these cell factories are usually in the order of 
mg/L to only a few g/L [29–31]. Notably, T. thermophilus 
has been genetically reprogrammed to generate platform 
chemicals, such as fumarate, directly from renewable 
feedstocks to replace petroleum-based processes, which 
is of interest for the manufacturing of synthetic resins, 
biodegradable polymers (up to 17 g/L) and malate (up to 
200 g/L) [32, 33]. The fungus has also been optimised by 
Dyadic International as a producer for biologics, includ-
ing vaccines, therapeutic enzymes, proteins and biosimi-
lars [34].
Filamentous fungi as meat replacements
The use of fungi as a source of food predates recorded 
history [35]. These have been predominantly the mush-
rooms from supermarket shelves and foraging expedi-
tions. The fruiting bodies of these fungi have a wide 
variety of tastes and textures and some of these are 
considered very meat-like, for example “Chicken of the 
Woods” (Laetiporus sulphurous) and “Beefsteak fungus” 
(Fistulina hepatica). There has recently been a move to 
create meat-like products from fungal mycelium grown 
in fermenters, rather than the solid fruiting bodies. This 
has allowed the introduction of ascomycetes, tradi-
tionally used as flavour modifiers in such foods as blue 
cheese, to enter the food chain as convincing meat substi-
tutes. The longest established of these companies is Mar-
low Foods, using Fusarium venenatum under the trade 
name Quorn™, but several other companies have recently 
shown an interest in this area, including Mycorena (A. 
oryzae; [36]), Sustainable Bioproducts (F. oxysporum; 
[37]) and MycoTechnology, using the basidiomycete 
Lentinula edodes [38]. The hyphae of filamentous fungi, 
when aligned and organised, provide a structure that 
looks like and has the mouth feel of meat, particularly 
chicken, due to the similarity of fibre size (Fig.  3). The 
high amino acid and fibre content, and low saturated fat, 
combined with the high digestibility of fungal protein 
(see Additional file 1: Table S1), make this an exception-
ally healthy food [39].
The fungi for food replacements are grown in ferment-
ers on simple salts and glucose as the carbon source. 
Quorn™ uses air lift pressure cycle fermenters (Fig.  4). 
These are 30  m tall and have an operating volume of 
approximately 150  m3, which offer several operational 
and control benefits over conventional fermenters, 
including low shear stress allowing longer (and, there-
fore, higher quality) hyphae.
Glucose can be provided from several sources, cur-
rently by enzymatic digestion of starch from wheat or 
maize using the enzyme glucoamylase from A. niger, but 
lignocellulose is being considered for the future. As the 
protein from the original grain is retained for other uses 
and not fed to F. venenatum, the metric of the amount of 
protein per hectare, used to compare many animal pro-
teins, is misleading when applied to fungi. The use of pro-
tein in animal feeds, whether animals or insects, acts to 
concentrate (with losses) what is present in the original, 
whereas fungi add protein to a protein-free feedstock. 
Page 7 of 23Meyer et al. Fungal Biol Biotechnol             (2020) 7:5  
Furthermore, production of fungal protein is highly 
water-efficient in comparison to animal protein, requir-
ing about one-tenth that of beef and half that of chicken. 
Quorn Foods was the first global meat alternative brand 
to achieve third party certification of its carbon footprint 
figures [40]. However, there is considerable potential to 
reduce the ecological impact of fermented F. venena-
tum further, and, as such, Marlow Foods are pursuing a 
research programme involving multiple external partners 
looking at water reduction, carbohydrate choice, fer-
menter optimisation, co-product valorisation and more.
Filamentous fungi as biomaterials
Fungi thrive by decomposing and consuming dead plants 
by breaking down the plant’s cellulose, lignin and other 
sugars, then rearranging these molecules into their own 
biomass to grow. Their cell wall is secured by chains of 
chitin and glucans, which, like cellulose and keratin, are 
naturally forming polymers found in the toughest of 
organic tissues. Chitin is the same ingredient that creates 
the durable and flexible exoskeletons of insects and shell-
fish [41]. During the colonisation of substrates, hyphae 
bind the organic particles together, while degrading them 
simultaneously. A composite material is obtained, con-
sisting of a bulk of organic substrate bound together by 
the hyphal network, by inactivating the fungus before 
the substrate is degraded (e.g. by drying or by heat inac-
tivation). Pure fungal materials are obtained by complete 
degradation of the substrate or removing the fungal skin 
from the substrate. Both pure and composite mycelium 
can be used for different applications [42].
Stopping fungal growth during colonisation of the sub-
strate results in materials with properties similar to that 
of expanded polystyrene or other foams (Fig. 5; [43, 44]). 
Such materials can be used as packaging material or for 
heat or acoustic insulation. The properties of both com-
posite and pure mycelium materials are dependent on the 
substrate, the type of fungus, the growth conditions and 
post-processing. Heat pressing, for instance, improves 
the homogeneity, strength and stiffness of the mycelium 
composite material, shifting its performance from foam-
like to cork- and wood-like (Fig. 5; [45]). A range of myce-
lium composite materials with different properties can be 
produced [46]. Future studies should focus on the coating 
of mycelium materials to reduce water uptake and vola-
tile organic compound escape. The genetic engineering of 
strains, however, may make coating superfluous.
Mushroom-based materials have the potential for 
uses in place of leather, textiles and some plastics. The 
strength of pure mycelium of a wild-type S. commune 
strain is similar to that of natural materials, such as wood 
and leather [47]. By contrast, a material can be obtained 
by deleting a gene that encodes a protein called hydro-
phobin, that pearls off water droplets from fruiting bod-
ies, with a strength similar to that of thermoplastics. 
The difference in the material properties between these 
strains is explained by a better packing of the hyphae 
in the deletion strain, resulting in an increased density 
of the mycelium. In addition, the absence of the hydro-
phobin in this strain results in a mycelium that is no 
longer water-repellent, consequently, it absorbs more 
water and dries more slowly than the wild-type [47]. 
Fig. 3 Unique textural attributes of Quorn™. Electron microscopic images of protein fibres from spun soya and chicken and hyphal filaments of F. 
venenatum. Bar, 100 µm
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Fig. 4 The Quorn™ fermentation process. A continuous supply of medium is fed into the fermenter and the broth is harvested simultaneously. 
The harvested broth is heated to a temperature that destroys proteases but leaves RNAses active, allowing the RNA content of the mycelium to 
be reduced to less than 2%, which is a regulatory requirement. Once the broth has been heat‑treated, the mycelium is spun down to form a paste, 
which is mixed with binders and flavouring agents before being shaped, cooked and frozen. The supernatant from the paste is currently sent for 
treatment as wastewater, but active research at Marlow Foods is looking into how the 1.5% solids in the waste can be recovered as a food grade 
co‑product
Fig. 5 Material properties that can be achieved with fungal mycelia. a Mycelium composites. b Mycelium textiles. The pictures depicted are 
reproduced from [45], which has been published under a Creative Commons Attribution licence (CC BY, http://creat iveco mmons .org/licen ses/
by/4.0/)
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Thus, mycelium-based materials can provide desir-
able mechanical properties which can also be bio-per-
formative, for example, by buffering water availability. 
Future studies, therefore, should focus on not only the 
mechanical but also bioactive properties, making myce-
lium a potential source of new innovative materials with 
advanced properties. Future studies should also reveal 
whether mycelia can be utilised to develop materials with 
properties similar to the material families of the elasto-
mers, composites, metals and ceramics (Fig. 5).
The flexibility and aesthetics of mushroom materials 
were first appreciated by artists and designers who used 
them to grow living art works [48, 49]. Similar to cement 
and plaster, mycelia will bind, harden and set into a vari-
ety of solidified configurations. These designers and art-
ists soon discovered that materials grown from this dense 
living matrix could be used to make advanced compos-
ites, foams and performance plastics, and the commercial 
potential soon followed. Companies that are designing 
and engineering mycelium materials include MycoWorks 
[50], Ecovative Design [51], NEFFA [52] and MOGU [53], 
to name but a few. Research programmes at MycoWorks 
proved that fine mycelium materials can be grown into 
the texture of sheet urethanes, animal skins and foams, 
with surfaces that are velvety and fluffy, leathery and rub-
bery, or beetle-shell brittle and shiny. After a mycelium-
based object has been grown, it can be cut, processed and 
machined like many other materials. Demand for these 
materials has been driven by concerns for stabilizing the 
price of supply chains into the future. One of the first 
markets for which fungal mycelium can provide a solu-
tion is the fashion industry, where there is both a con-
sumer and market demand for alternatives to the animal 
skins and plastics used to make apparel. A sensual and 
strong material for luxury fashion has been developed 
by moulding the body of the mycelium into a sheet and 
processing it in many of the same ways as animal leather 
(Fig. 6).
Notably, mushroom-based materials can absorb and 
dissipate a variety of energetic forces, ranging from 
sounds to seismic waves to ballistics [54]. They are natu-
rally flame retardant, good thermal insulators and can be 
grown as flexible or rigid as one desires [50, 55]. While 
incredibly strong and durable, these materials can readily 
be broken down into constituent minerals and dispersed 
easily back into the world. Materials grown through a 
process of fermentation and decomposition require far 
less energy, water and other resources than conventional 
manufacturing.
Filamentous fungi and a wood‑based bio‑economy
In order to shift away from a fossil-based economy and 
mitigate climate change triggered by the continuous 
industrial overproduction of  CO2, many countries around 
the world, including those of the European Union, sup-
port the transformation to a renewable, bio-based and 
resource-efficient economy. Wood is considered to play 
a key role in the efforts towards this goal, due to the large 
Fig. 6 MycoWorks’ fungal analogues for composites and leather. a Analogues for synthetic wood composites and expanded polystyrene foams. 
Mushrooms are very sensitive to their surroundings, and it is possible by altering subtle factors to make their tissue express a range of variably 
determined physical characteristics. While these materials can be grown into building components for construction and interior architectures, they 
can also be grown with delicately tuneable qualities. The strength, durability and biodegradable nature of mushroom‑based materials suggest 
many ways in which fungi may be used. When the material is processed with traditional industrial wrapping and laminating equipment, it is 
possible to create functional materials. b Analogues for animal leather. The MycoWorks technology is able to tune fine mycelium leather to have 
material advantages similar to animal skin, becoming supple, elastic and strong, with excellent return, drape, compression and insulation. This 
mycelium leather, launched in early 2020 as Reishi™, has been designed as a drop‑in material for existing leather processing machine tools, where it 
can be cured, finished and manufactured using well‑honed industrial techniques and formulas
Page 10 of 23Meyer et al. Fungal Biol Biotechnol             (2020) 7:5 
potential of forests and wood products to sequester car-
bon [56, 57]. The term “sustainable” originates from 
forestry, initially coined by a German mining adminis-
trator, Hans Carl von Carlowitz, more than 300  years 
ago, who oversaw the timber supply of silver mines and 
realised that regrowth did not match the consumption 
rates [58]. Although the concept of “sustainability” has 
substantially broadened over time, it became a guiding 
concept in forestry, and recent surveys are demonstrat-
ing that European forests are still showing positive net 
annual increments [59] and are, therefore, actively stor-
ing carbon—a prerequisite for any economy that strives 
to become net carbon-neutral.
Current wood utilisation includes three major streams: 
energy, wood products, and pulp and paper, with about 
60% going towards materials and 40% into energy in 
Europe. In this way, about 20% of the total carbon in 
use is annually sequestered into long-life materials [60]. 
However, in order to keep carbon stored within materials 
for as long as possible, a circular economy will be ben-
eficial, including both recycling and reuse of wood prod-
ucts in a cascading fashion [61] before a final utilisation 
for energy services. Since an increased demand for and 
scarcity of wood can be expected with the transition to a 
bio-based economy, such resource efficiency will become 
even more important in the future. While high-quality 
wood would, therefore, be optimally used as timber for 
solid products initially, later utilisation steps in a virtual 
cascade would focus on the inherent fibres, polymers and 
monomeric wood constituents, such as sugars and lig-
nans. This is where filamentous fungi have their highest 
potential to assist due to their natural ability of selectively 
and efficiently degrading and/or modifying all of these 
major wood constituents.
Due to the natural ability of fungi as heterotrophic 
organisms to efficiently degrade lignocellulosic plant bio-
mass and convert the constituent sugars into energy-rich 
molecules, filamentous fungi or fungal enzyme cocktails 
have a high potential to be employed in the upgrading of 
wood in biorefinery applications towards second-gen-
eration biofuels or chemicals [62]. Up to now, however, 
mostly straws are used as substrate for these processes 
(e.g. the  Sunliquid® process by Clariant), with only a 
few examples of wood conversion (e.g. bioethanol from 
Borregaard); wood being much more recalcitrant, due 
to generally higher lignin contents among other things 
[63]. Considering all of the above, an integration of bio-
technological processes using fungal platforms into pulp 
and paper mills which are already performing (chemical-
based) wood separation, such as Kraft pulping, can be 
envisioned as having substantial technological and eco-
nomic advantages [64].
Such “wood-based biorefineries” already exist—mostly 
in Scandinavia and eastern Europe [65]. Nevertheless, 
most of these are far from being true multi-product fac-
tories. Optimally, biorefineries would integrate biomass 
conversion processes and equipment to produce bioen-
ergy and a range of products, including pulp, bio-based 
chemicals (e.g. for food and pharma), biofuels, electric-
ity and heat. Regarding efficiency, the ability to use mul-
tiple feedstocks, such as those originating from pulping 
processes (pulpwood, extracts from effluents, fractions of 
pulping liquors), by-products from sawmills (e.g. wood 
shavings), or recovered materials (e.g. recycled paper 
and wood/fibre waste), would be advantageous. Many 
of these substrates are unsuitable for chemical upgrad-
ing due to their low purities and would have to undergo 
costly cleaning steps. Filamentous fungi, on the other 
hand, have the potential to circumvent these problems, 
since many are surprisingly robust against inhibitors and 
can selectively transform desired target compounds out 
of complex mixtures, including lignin-derived molecules 
[66].
In summary, wood-based biorefineries can play a cen-
tral role in the transition towards sustainable economies, 
with the ability to generate commercial resources with 
a smaller carbon footprint of resources and emissions 
than traditionally produced materials (such as concrete). 
However, which product systems are the most promis-
ing ones regarding sustainability and efficiency must be 
assessed. Filamentous fungi can be of great value in these 
efforts and help to move more wood from energy into 
material use and, thus, to higher value creations. Never-
theless, substantial challenges and knowledge gaps can be 
identified that need to be addressed to be successful in 
the mid- to long-term:
• Research in wood decomposition is lagging behind 
that for more readily degradable biomass, such as 
agricultural residues and straws.
• Considering the benefits of using recovered (pre-
used) wood products, pulp mill side streams and for-
estry/wood industry residues, the research and adap-
tation of fungal cell factories should include these to 
a much greater extent than done today.
• Climate change is slowly altering the tree composi-
tion, and it can be expected that hardwoods, such as 
beech and oak, will replace the more drought- and 
pathogen-sensitive softwoods, such as the currently 
predominating spruce, in the future. These types of 
wood differ in their composition, with clear impli-
cations for fungal degradation [67, 68]. Directed or 
engineered fungal adaptation and the optimisation 
of fungal enzyme cocktails will be needed to address 
these differences in order to optimise utilisation.
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• Lignin is the most underutilised of all wood polymers 
due to its complex structure and difficulties in pro-
cessing. It forms an amorphous network of phenyl 
propane units coupled to hemicellulose via ester link-
ages. It is the second most abundant natural material 
on Earth after cellulose. The worldwide production 
of lignin is approximately 100 million tons annually 
[69]. One of the main challenges of lignin valorisation 
lies in its diverse structure and poor solubility. Most 
of the lignin obtained (Kraft lignin/black liquor) is 
incinerated directly in the pulping plants to recover 
energy. Only about 2% of the technical lignin glob-
ally available (~ 5 million tons) is currently utilised. 
Basidiomycetes are unique in their vast abilities to 
modify and/or mineralise lignin, and these organ-
isms should play a central role in developing the util-
ity of this highly promising polyphenol. The poten-
tial of lignin as a material reservoir will be achieved 
through much more rigorous characterisation of the 
structure/function predictability achieved through 
these fungal transformations.
Filamentous fungi to mitigate plastic pollution
Plastics are widely used in the global economy because 
they are inexpensive, versatile, lightweight and durable. 
Millions of tons of plastics accumulate in the environ-
ment annually due to their stability, poor recycling and 
low circular use, and they represent an ecological threat 
to nature and human health. At least 350–400 million 
tons of plastics are being produced annually worldwide 
[70], while its production keeps increasing by an average 
of 7% per annum. In 2014, for example, 311 million tons 
were produced, among these, 59 million tons in Europe. 
About 64% of the total European plastic demand is con-
centrated in five countries: Germany, Italy, France, the 
United Kingdom and Spain. The main types of plastics 
are polyethylene, polypropylene, polyvinyl chloride and 
polystyrene [71]. In 2014, the plastic waste in Europe 
amounted to 25.8 million tons that were recycled (30%), 
subjected to incineration for energy recovery (40%) or 
sent to landfill (30%). Efficient recycling and incineration 
are only practiced in a few countries, while in most coun-
tries, more than 50% of plastic waste is landfilled [71]. The 
latter undergo photo oxidation, degradation and mechan-
ical disruption that often give rise to small fragments, i.e. 
microplastic particles [72]. Microplastics, plasticizers and 
plastic additives as well as added monomers and oligom-
ers can enter surface and/or ground water and accumulate 
in the environment exerting toxic effects [73]. Approxi-
mately 5 to 13 million tons of plastic waste enters the 
Earth’s oceans every year, as the intentional or uninten-
tional final destination [74]. When this waste is ingested 
by marine animals, it accumulates in the food chain [72]. 
The most abundant type of primary microplastics in water 
environments are fibres [75] that originate from washing 
synthetic textiles. Replacing synthetic textiles with myce-
lium-based textiles can be a means to greatly reduce plas-
tic pollution. In addition, fungal materials could replace 
plastics in a variety of other applications (see above).
Current plasticizers are used, among other things, to 
improve the workability of concrete, the construction 
material most used in the world. Plasticizers enable the 
use of less water by keeping the same viscosity of the 
concrete, thereby producing a highly workable material 
that hardens into a strong final product. Plasticizers are 
typically not covalently bound to the polymers, which, 
over time, may lead to environmental contamination 
via leaching [73]. A bio-based alternative to the current 
fossil-based concrete plasticisers would be lignin func-
tionalized to a higher solubility by the action of fungal or 
bacterial laccases or other oxidative enzymes. The very 
hydrophobic lignin is insoluble in water and alcohol but 
soluble in alkaline solutions. Fungal laccases are preva-
lent in asco- and basidiomycetes and are typically most 
active at low pH values of 3–5.5, which is a drawback for 
their use in functionalizing lignin. Accordingly, laccases 
have to be identified or engineered that have a shifted 
optimum pH towards an alkaline pH. One recent success-
ful approach at AB Enzymes has been the engineering of 
a laccase from the ascomycete Melanocarpus albomyces 
using a directed evolution approach, which has led to 
threefold improved kinetics at pH 9.8 [76]. Notably, the 
principle applicability of laccase-functionalized lignin 
has been shown, but immediate commercial implementa-
tion is hindered by the general availability and inexpen-
sive cost of fossil-based plasticizers.
To date, very little is known about the biodegradabil-
ity of petroleum-derived polymers and plastics with 
fungi and only a few reports are available in the litera-
ture. Many basidiomycetes are generally known for their 
ability to degrade polycyclic aromatic hydrocarbons and 
are applied in bioremediation processes of contami-
nated soils and liquids [77–80]. So far, plastic-degrading 
fungi have been successfully isolated from weathered 
plastic waste obtained from marine habitats and terres-
trial waste treatment facilities. The main fungal genera 
that were isolated and used for lab-scale plastic deg-
radation, primarily of PET and polyurethane so far are: 
Acremonium, Alternaria, Aspergillus, Aureobasidium, 
Cladosporium, Debaryomyces, Emericella, Fusarium, 
Gliocladium, Mucor, Nectria, Neonectria, Penicillium, 
Phoma, Plectosphaerella, Rhizopus and Trichoderma 
[81–84]. In addition, enzymes produced by basidiomy-
cetes (Agrocybe aegerita, Auricularia auricular-judae, 
Bjerkandera adusta, Nematoloma frowardii, Pycnoporus 
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cinnabarinus, Stropharia rugosoannulata) have been 
identified and used for plastic degradation. Among the 
most promising enzymes used for PET and polyure-
thane treatment have been esterases, cutinases, lipases 
and lignin-modifying and unspecific macromolecule-
depolymerising and hydrolytic enzymes, such as different 
peroxidases, laccases, glucose oxidases and cytochromes 
P450. However, no distinct degradation effects for vir-
gin and pre-treated plastics have been achieved solely by 
the use of pure enzymes [70]. Hence, currently ongoing 
research is focused on mycelial-based degradation (whole 
cell degradation) of pure or mixed cultures in combina-
tion with purified enzyme cocktails.
The Janus face of filamentous fungi
The fungal kingdom is huge: six million species are esti-
mated to exist on Earth [85], of which only a small pro-
portion is known. Most are saprophytes and feed on dead 
plants and animals, and only a few dozen are exploited 
in biotechnology as cell factories. Leveraging their meta-
bolic capacities and flexibilities will be key to achieving 
the circular economy outlined above (Fig. 2).
However, many filamentous fungi pose a threat to plant, 
animal and human life. As comprehensively covered 
in the first white paper of the EUROFUNG consortium 
published in 2016 [4], a multitude of plant-pathogenic 
fungi destroy staple crops annually, which would be 
enough to feed 600 million people [86]. Human-path-
ogenic fungi compromise the life of 1.2 billion people 
worldwide and kill about 1.5–2 million annually, exceed-
ing the fatalities caused by malaria or tuberculosis [87]. 
Regarding more information on the huge impact of fun-
gal pathogens on human health and food security and the 
related challenges, the interested reader is referred to the 
EUROFUNGs white paper from 2016 [4], a review cover-
ing the top 10 most feared fungi published in 2018 [88] 
and to the One Health report published by the American 
Academy of Microbiology in 2019 [89].
Meeting the agricultural production required to feed 
the increasing world population [90] is likely to be made 
more difficult by climate change. This problem is exac-
erbated by a wide range of plant diseases caused by the 
diverse group of fungal and newly emerging pathogens. 
A list of the ten most important fungal pathogens of 
plants published in 2012 [91] is outdated. If this list had 
been collated more recently it would have undoubtedly 
also included the basidiomycete Phakopsora pachyrhizi, 
which causes Asian soybean rust and threatens the sus-
tainability of the millions of hectares of soybean grown 
in Brazil each year, despite only being detected in Bra-
zil for the first time in 2001 [92]. Soybean production is 
now only viable in Brazil because of the availability of 
effective fungal control agents. However, even with the 
solutions available from the agricultural industry, crop 
losses remain high in soybean and a wide range of other 
crops [93]. In many cases, the losses seen are due to fungi 
that have developed resistance to existing control strate-
gies [94–96]. The speed with which many species of fungi 
evolve and become resistant to existing control strategies 
means that there is a constant need to identify agents 
with novel modes of action. However, the development of 
novel fungicides by companies active in this field, such as 
Bayer Crop Science and Syngenta, requires a huge effort 
and major investment (Fig. 7), taking more than 10 years 
from the identification of a new screening ‘hit’ to market 
[97].
The screening of hundreds of thousands of random 
chemical inputs has historically produced a very low 
yield of hits, therefore, hypothesis-driven input selection 
methods are increasingly being utilised. However, the 
current target assessment and prioritization approaches 
are still heavily reliant on information from ‘model’ fun-
gal systems, such as S. cerevisiae and Neurospora crassa, 
rather than on good quality data produced from fun-
gal pathogens that result in the highest crop losses. It 
is remarkable that almost all plant pathogens diverged 
from the fungal ‘model’ systems millions of years ago 
and have very diverse modes of pathogenicity [98–100]. 
Therefore, the reliance on these classic ‘model’ systems 
is deeply unsatisfactory and a significantly better under-
standing of the genetics and metabolism of fungal plant 
pathogens is likely to help deliver novel fungal control 
strategies. In this respect, it is worth mentioning that the 
EUROFUNGs white paper from 2016 stressed that the 
term ‘model’ is misleading and advocated a shift in focus 
towards ‘reference’ strains [4].
Some ubiquitous filamentous fungi which are not 
pathogenic and usually thrive on dead plant material are 
still dangerous for human health when consuming crop-
based products. Filamentous fungi produce a plethora of 
so-called secondary metabolites (SMs), of which a sub-
set, the mycotoxins, are harmful. These can be produced 
by fungi growing either on the crops, some without dis-
turbing plant growth, or post-harvest. The SMs are syn-
thesised by accessory biosynthetic pathways thought to 
be important for a range of processes, including spore 
development, spore survival and fungal communication. 
Recent advances promote the view that fungal mycotox-
ins are fitness factors that help to establish a niche for 
protection from competing microbes [101, 102].
Mycotoxins are toxic, carcinogenic and/or mutagenic 
fungal SMs and can be present in high concentrations in 
food and feed products. Mycotoxins have significant eco-
nomic effects on a wide number of crops, most commonly 
but not exclusively contaminating grain crops (maize, 
wheat, barley), peanuts and tree nuts, beets, grapes and 
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coffee. The Food and Agriculture Organization has esti-
mated that 25% of the world’s crops are contaminated with 
unacceptable levels of mycotoxins. Economic losses are 
not easily quantified, but based on the reports that exist, 
losses are staggering. Aflatoxin, for example, is the most 
problematic mycotoxin, with estimated annual losses due 
to contamination ranging from $52 million to $1.68 bil-
lion regarding the US corn crop alone [103]. A relatively 
small number of ascomycete genera—Aspergillus, Penicil-
lium, Fusarium, Claviceps and Alternaria—produce most 
of the common mycotoxins. Major mycotoxins include 
aflatoxins, citrinin, cyclopiazonic acid, ergot alkaloids, 
fumonisins, ochratoxin, patulin, trichothecenes and zea-
ralenone [104]. All these metabolites have adverse effects 
on vertebrate cells depending on the amount ingested and 
the age and sex of the consumer. Aflatoxin  B1 is the myco-
toxin most studied and the mechanism by which it causes 
liver cancer is well understood [105]. Trichothecenes, 
which interfere with protein synthesis in animals and 
humans, are common contaminates of wheat and a huge 
problem across all wheat-growing regions in the world. 
Patulin is of especial concern as it is frequently found in 
apples and products derived from apples that are popu-
lar children’s foods, such as apple sauce and juice [104]. 
It has also been proposed that SMs cause adverse human 
health effects after exposure by inhalation (e.g. exposure 
to moulds indoors; [106]).
Although the molecular genetics of many mycotoxins 
is well understood [104], efforts to control the contami-
nation of food and feed with these small molecules is 
still to be realised. Aside from the challenges of control-
ling mycotoxin contamination using traditional efforts, 
such as breeding plants for resistance and/or detoxify-
ing contaminated products, several emerging issues have 
complicated the ability to tackle the mycotoxin prob-
lem. Four significant issues to be considered in relation 
to mycotoxin amelioration are: (i) masked mycotoxins, 
(ii) climate change, (iii) emerging mycotoxins and (iv) 
co-occurrence of mycotoxins. Masked mycotoxins refer 
to plant derivatives of fungal mycotoxins. There is con-
cern and data to support that these hybrid molecules 
can contribute to toxicity either directly or indirectly 
through the release of the parent mycotoxin in ani-
mal digestive tracks [107]. Research groups worldwide 
Fig. 7 From science to market—the fungicide discovery and approval pipeline. Historically, the biological activity profile (fungicidal potency 
and spectrum) was used to filter hit compounds to lead molecules. Nowadays, regulatory requirements regarding human and ecotoxicological 
safety mean that proxy assays for these regulatory requirements are now utilised as early in the discovery pipeline as possible as part of the 
selection criteria for compound progression. It will typically take 10–12 years for a new fungicide to pass through the various stages of research 
(lead generation, early and late lead evaluation, optimisation and candidate confirmation) before promotion into evaluation and, finally, product 
development. After reaching the market, a significant amount of investment is still required for product lifecycle management (e.g. product 
monitoring feeds into improvements in formulation)
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are now examining how climate change might impact 
mycotoxin synthesis for diverse fungi and crops. Several 
studies suggest increases in mycotoxin contamination 
although predictive modelling approaches need to be 
refined [108–110]. Emerging mycotoxins refers to toxic 
molecules that occur frequently in products but are not 
consistently monitored (e.g. eniatins, alternariol, emodin 
and sterigmatocystin; [111]). The frequency and occur-
rence of these less common mycotoxins should ideally be 
subject to risk assessment. Finally, many mycotoxins co-
occur in the same crop, yet, worldwide regulations only 
consider the toxicology of a single mycotoxin [112]. Little 
is known whether combinations of mycotoxins affect the 
consumer in an antagonistic, additive or synergistic man-
ner. Despite the wealth of published works on the topic of 
mycotoxins, substantial gaps remain in the knowledge of 
how to reduce contamination, what quantities are impor-
tant in health, whether co-occurrence is a topic to con-
sider and how climate change will impact future risks of 
these fungal metabolites.
Measures to advance science on filamentous fungi
Exploiting and fighting fungi for a sustainable, resource-
saving bio-economy that operates in a circular manner 
demands considerable improvements in research and 
development on scientific and community levels:
• Science: (i) improved understanding of fungal biol-
ogy in a diverse set of species and strains, including 
lab (reference) strains, industrially exploited strains 
and ecologically relevant species; (ii) improved 
high-throughput technologies and tools to study the 
dynamics of fungal growth, product formation and 
pathogenicity and their adaptation to changing envi-
ronmental conditions; (iii) investment in the stand-
ardisation of measures, methods and automation 
tools; and (iv) investment in open access infrastruc-
tures for the storage, analysis and reuse of systems 
biology data, including biofoundries.
• Community: (i) overcoming fragmentation of the 
research community studying filamentous fungi; (ii) 
increasing the number of scientists devoting their 
lifetime to the study of fungi; (iii) the improved inter-
sectoral and interdisciplinary education and training 
at undergraduate and graduate levels; and (iv) the 
engagement of scientists and educators in public out-
reach and the dissemination and engagement of the 
general public in fungal science.
The science on filamentous fungi has always been lag-
ging behind that on many other microorganisms, such as 
yeast and bacteria. Four main reasons for this delay can 
be specified: firstly, genetic transformation of filamentous 
fungi is less efficient and more time-consuming com-
pared to unicellular bacteria and yeast [113]. Secondly, 
genome sequences of filamentous fungi only became 
available a decade after the genomes of the ‘model’ uni-
cellular fungus S. cerevisiae (1996; [114]) and the ‘model’ 
bacterium E. coli (1997; [115]) were released to the pub-
lic. Thirdly, the genomes of filamentous fungi contain far 
more genes. A filamentous fungal genome usually car-
ries between 9000 and 14,000 genes, whereas E. coli has 
about 4000 and S. cerevisiae about 6000 genes. Finally, 
there are a few million fungal species, consequently, the 
research communities studying a particular filamentous 
fungus are considerably small and fragmented. Each fila-
mentous fungus is an individual of its own, different from 
all the other fungi, although its outlook is covered by the 
universal filamentous form. One of the largest of these 
scientific communities, studying A. niger, consists of only 
about 30 research labs worldwide [2], whereas more than 
1800 research labs studying S. cerevisiae are registered at 
the Saccharomyces Genome Database [116].
Some substantial measures for basic and applied sci-
ence on filamentous fungi are highlighted in the follow-
ing. These need to be addressed in the short- to mid-term 
in order to fully leverage the power of these microorgan-
isms for a circular economy.
Community engagement and sustainable infrastructures 
for high‑quality fungal omics data
Biology has entered the digital age in many ways, most 
obviously with the rapid growth of large datasets, includ-
ing genomes, transcriptomes, proteomes, phenomes and 
metabolomes. The exploitation of these data underpins 
the future of biology but requires effective infrastructure, 
supported and facilitated by easily accessible online tech-
nologies delivering high-value analyses. However, this 
revolution presents major technological challenges and 
resource implications. This is particularly stark for the 
fungal research community, due to the diversity of both 
the organisms and fields of research. On top of this, a 
vast amount of biological information and data is not in a 
searchable, digital form but is buried throughout our rich 
and varied literature.
Omics data is very cost-effective, but its utility is largely 
dependent on making the data accessible and usable 
for the wider research community. Every effort should 
be made to develop the future of genomics-driven fun-
gal research in order that everyone can have full access 
to reliable genomic information. Consequently, access-
ing and representing diverse aspects of biology, ranging 
from phenotypes and subcellular localisation to protein 
interactions or the geographical location of isolates, 
in a searchable format is not easily achieved or read-
ily automated. Therefore, a lot of the work required is 
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time-consuming and requires dedicated personnel with 
biological expertise and information technology skills 
to apply appropriate classifications and ontologies. New 
solutions are needed for a large amount of multispecies 
omics data comparison. Addressing these issues requires 
co-ordination between researchers, publishers and data-
bases, so that, at the time of publication, key information 
is deposited in a logical way within these resources. This 
will require the community to act proactively to facilitate 
the integration of data, consistency in the use of termi-
nology and gene names, and journals to consider these 
issues when defining their requirements for data depo-
sition and developing practices to facilitate text mining 
[117].
Fungal genome sequences are hosted at several fun-
gal databases (e.g. FungiDB [118], JGI MycoCosm [119], 
Ensembl Fungi [120]), many more genomes are depos-
ited in the NCBI, ENA or DDBJ, and some are hosted by 
private resources. Free, open access to data is generally 
accepted as a key priority, which, consequently, requires 
significant long-term funding for well maintained and 
resourced, actively developing databases to serve their 
user communities. Many funding organisations have 
contributed to setting up and maintaining bioinformatic 
resources, but the required long-term commitment is 
difficult to obtain, and with an inevitable cliff edge each 
time renewal of funding is sought, the reality is that key 
resources have been lost and will be lost in the future. A 
consequence of the funding issues is a general drive to 
centralise, with a number of organism-specific resources 
having been closed down or frozen (e.g. AspGD), due to 
a loss of funding. How to address this global issue is not 
easy and needs both engagement and commitment from 
funding agencies and/or governments, alongside con-
certed efforts from the community to shape policy. Alter-
native funding models must also be considered. However, 
most proposals potentially endanger the ethos of full 
open access.
Early genome sequences were limited in quality due 
mainly to the sequencing technologies used; more recent 
higher quality and better assembled genome sequences 
suffer from poor annotation. In the early days, consortia 
were formed to improve upon the automated gene calling 
and annotation by manual curation and verification of 
genes. Nowadays, very few genomes make it past the ini-
tial draft annotation [4]. Consequently, errors are likely 
to occur, and these will be perpetuated and propagated 
in the annotation of other genomes, influencing down-
stream experimental analysis. Additionally, comparison 
of outputs from different bioinformatic pipelines using 
the same datasets will generally not give exactly the same 
interpretation—the outputs represent probabilities and 
models are, thus, not absolute. The resulting differences 
inevitably complicate the comparison of genomes and 
other types of data. Lack of awareness or technical 
understanding can also lead to the misinterpretation and 
misinformation of any programme or bioinformatic out-
put. This underlines the need for improved training and 
development, not only for dedicated bioinformaticians 
but even more for biologists in general. Currently, there 
is a serious lack of qualified personnel with adequate 
formal training. Consequently, as a minimum, there is a 
need for appropriate training regarding accepted rules 
for omics data handling, enabling fungal biologists to effi-
ciently contribute their domain-specific expertise using 
ontologies, terminologies and platforms that minimise 
the need for professional curation and maximise value to 
the broader user community.
Databases, such as FungiDB and MycoCosm, have 
a challenge in choosing the organisms and datasets 
they should host and on where the particular reference 
genomes, their limited annotation and curation efforts 
should focus. Consequently, the active engagement with 
and involvement of researchers is essential in making 
these decisions. Most researchers inevitably regard their 
own work as a priority and there is a danger that those 
with the ‘sharpest elbows’ will prevail. Therefore, it is 
important that communities ensure they are well rep-
resented and informed of decisions, proposed priorities 
and opportunities.
Opportunities and challenges in getting value from fungal 
omics data
The integration of databases provides opportunities for 
shared resources and infrastructures which have inevi-
table cost-savings. ClinEpiDB [121, 122], for example, 
accommodates a diverse range of large-scale epidemio-
logical datasets for enteric, respiratory and parasitic 
pathogens but no fungal data. The common infrastruc-
ture used by ClinEpiDB and FungiDB could potentially 
facilitate the integration of epidemiological datasets for 
fungal pathogens and, as such, allow room for innova-
tion. These resources, allowing the mapping of disease 
and genomic data, could be potentially developed more 
broadly for fungal researchers interested in plant dis-
ease, ecology and the migration of key pathogens or drug 
resistance. Additionally, this may facilitate new develop-
ments to include the characterisation of transcriptional 
changes associated with host pathogen interactions [123] 
or between microbiomes [124].
A major challenge for both the database providers 
and their users is that data is not static nor is the inter-
pretation of data generally limited to a single definitive 
result. Genomes, for example, may be re-sequenced 
using new technologies and additional datasets, such 
as proteomics or RNA-Seq, are constantly being added. 
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These changes and additions, alongside modifications 
to bioinformatic pipelines, will facilitate improved gene 
calling and annotation. Consequently, gene models may 
be removed or split, misannotated open reading frames 
revised, differential splicing revealed and untranslated 
regions, defining the transcription start sites and mature 
3′ ends, clarified. These changes can result in difficul-
ties. It is challenging, for example, to map all N. crassa 
knockout mutants to the current gene models hosted 
by different databases. Researchers, therefore, need to 
be aware that genomes are not set in stone but evolve 
with data and technical advances and the databases 
must make these changes clear and traceable. Updating 
repository records is paramount to ensure that all data-
bases have access to the most recent information and, 
as such, provide the best possible service to their users.
Another confounding factor when harnessing genome 
data of filamentous fungi is the fact that between 40 
and 50% of the genes in a filamentous fungal genome 
are ‘hypothetical’ and lack functional predictions [4]. In 
addition, only 2–10% of the genes with predicted func-
tions have been experimentally studied in filamentous 
fungi and, thus, have a verified function [125, 126]. This 
renders in silico reconstructed genome-wide metabolic 
models considerably incomplete, i.e. with gaps, dead-
end reactions and dead-end metabolites. Even for the 
‘model’ yeast S. cerevisiae, 21% of its predicted genes 
(i.e. about 1400 genes) still have dubious functional pre-
dictions in 2019, which is 22  years after the release of 
its genome sequence and despite a research community 
with more 1800 labs worldwide [127]. One powerful 
approach to overcome this limitation is the interrogation 
of gene expression networks based on hundreds of tran-
scriptomic datasets available for filamentous fungi. This 
wealth of data has recently been harnessed to improve 
gene annotations and assign gene function predictions 
to 65% of genes predicted in the A. niger genome [128], 
which now can be accessed at FungiDB.
Notably, ecologically important pathogens and endo-
phytic fungi have traditionally received very little support 
due to the absence of dedicated funding. Those manag-
ing the bioinformatics resource need to work with the 
researchers to define the types of data and criteria that 
apply when selecting datasets for inclusion so that the 
process is rigorous, not biased or arbitrary, and that 
appropriate computational workflows are developed in 
a timely way. This will also help the researchers to con-
sider relevant criteria when designing their experiments 
and specific initiatives may be developed to address par-
ticular problems. A key issue in confirming gene models, 
for example, is identification of the 5’ and 3’ ends of tran-
scripts. Most RNA-Seq approaches are poor at defining 
transcript ends, but specific approaches can be applied 
that address this directly. In this way, the structural anno-
tation of key genomes could be significantly improved for 
the wider community. Awareness of such issues may help 
the research community optimise the utility of their data.
Other on-line resources provide bioinformatic pipelines 
to assist and minimise the expertise required. One example 
is Companion [129], which provides a genome production 
pipeline. The most recent version has proved effective in the 
production of usable fungal genomes based on the de novo 
analysis of 25 previously characterised reference genomes. 
The future development and continued support of this and 
other such initiatives should help the lab-based research-
ers complete a good first draft of a genome annotation effi-
ciently without major resource implications. Furthermore, 
recent developments in the Apollo pipeline [130], integrated 
within databases such as VEuPathDB [131], allows research-
ers to inspect and modify genome features efficiently and 
can also be utilised in private workspaces. Data can remain 
private to a specific work group and be transferred to pub-
lic databases when appropriate. Consequently, the research 
community can fully engage to develop shared resources. 
As these contributions can be attributed to their author, 
this can be acknowledged by the community and potentially 
lead to micropublications, incentivising participation and 
rewarding those who contribute.
Last but not least, the rapid evolution of sequencing 
and other high-throughput technologies requires active 
discussions to improve policies and infrastructure for 
data sharing, integration and analysis in order to resolve 
the bottlenecks and challenges faced. The changes will 
not happen overnight, but effective communication 
should involve all parties concerned, including the on-
line database providers, researchers, funding agencies 
and policymakers. In order for these amazing resources 
to be used to their full potential for high impact research, 
these different parties must actively strive to ensure we 
have effective data sharing policies that will ultimately 
result in long-term sustainability, accessibility and utility.
Improved tools and technologies to study fungal biology
The molecular and analytical toolkit available for fila-
mentous fungi has improved substantially during the 
4 years since the first white paper was published in 2016 
[4], demonstrating the high innovation potential of the 
filamentous fungal research community. Genome editing 
via CRISPR has become routine and is nowadays run in a 
multiplex manner for many reference strains [132, 133]. 
Fourier-transformed infrared spectroscopy has become a 
next-generation phenotyping technology to identify fun-
gal strains and their metabolic products [134], while the 
power of surface analysis tools, such as mass spectrom-
etry-based imaging techniques, has been exploited to 
identify changes that are brought about by filamentous 
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fungi and their enzymes when they attack and modify 
insoluble lignocellulose materials [135]. “Ready-to-
use-microfluidics” have been implemented to study the 
dynamics of fungal growth and fungal interaction with 
soil bacteria [136], X-ray microcomputed tomography 
has been successfully applied to study spatial distribu-
tion of hyphae within mycelia and diffuse mass transport 
therein [137, 138], and gene and protein networks have 
been developed to assist our understanding of filamen-
tous fungal biology holistically [128, 139].
Hence, the technological foundation is sound and 
powerful and no longer represents a critical hurdle for 
gaining knowledge on fungal biology. As of now, high-
throughput methods for automated cloning, cultivation, 
mining and screening of fungal strains are, unfortunately, 
not yet state-of-the-art.
Standardisation as a driver for engineering fungal biology
Standardisation is a key for success. Standard reference 
methods, measures, substrates and materials ensure reli-
able fabrication and reproducible production characteristic 
of advanced global industries, such as the semiconductor 
and forest products industries [140–142]. Engineering biol-
ogy, broadly called synthetic biology, is similarly benefitting 
from standardisation [143, 144]. The mycelium materials 
research community and industry are already benefitting 
from ASTM and ISO standards developed for products in 
the forest, textile and acoustic absorbance industries. Accel-
erating the development and adoption of standard reference 
materials, measures and methods across the mycelial mate-
rials community and beyond could enable advancements in 
basic science on filamentous fungi and engineering of fun-
gal-based bioproduction analogous to the advancements in 
the semiconductor industry. New options for sharing myce-
lium materials that reduce transaction costs, allow for redis-
tribution and enable commercial production could provide 
the incentive for the broad adoption of standard references, 
measures and methods that support reliable fabrication and 
reproducible science [145, 146].
Reliable, standardised measurements are critical to 
reproducible science [147]. Metrology formalizes reliable 
measurements, and advances in metrology for biological 
systems are greatly benefitting basic science and the engi-
neering of biology [148, 149]. Characterising organisms, 
substrates and production environments in real-time 
across orders of magnitude in the scale of space and time 
could accelerate the development of advanced fungal 
products while, simultaneously, benefitting basic science 
and the engineering of biological systems. As an example, 
standard metrological materials, such as well-characterised 
1 cm3 units of mycelium material, and metrological meth-
ods could help to co-ordinate practitioners across locations 
and resource settings, reduce manufacturing costs, reduce 
time to market and disseminate best practices [150].
The confluence of standard approaches and automation 
tools characteristic of modern semiconductor foundries 
have cultivated the semiconductor industry into one of 
the most significant in human history. Recent advance-
ments in the automated construction of synthetic organ-
isms are making biofoundries economically viable and 
they are increasingly being recognized by the life sciences 
research community as an essential infrastructure for 
basic and applied research [151, 152]. Companies such 
as Gingko Bioworks and Ecovative Design have invested 
substantial capital in biofoundries for constructing 
organisms and there is an emerging ecosystem of “cloud 
laboratories” that aim to provide practitioners access to 
automated labs without the need for large capital invest-
ments [153–156]. Biofoundries with capacities for con-
structing filamentous fungal organisms could build on 
recent work to synthesize the genomes of the bacteria 
E. coli, Caulobacter crescentus and the yeast S. cerevi-
siae, with the ultimate goal of enabling advancements 
in synthetic filamentous fungal organism construction 
analogous to the construction of JCVI-sc3.0 and Sc2.0 
[157–160]. Work to insulate biological systems from evo-
lutionary drift can enable the deployment of engineered 
biology for applications outside the research laboratory 
or commercial bioreactors, while mitigating biosafety 
and biosecurity risks [161]. Such is the promise of dis-
tributed fungal-based bioproduction that biofoundries, 
for example, for mycelium materials in support of basic 
science, engineering and production, strategically placed 
across the planet, could ramify into impacts surpassing 
that of the semiconductor industry.
Concluding remarks
We would not be able to live the life we are living with-
out the help of moulds and mushrooms from nature. 
Fungi are our present and they will shape our future. 
They are champions in recycling and material transfor-
mation; their biosynthetic capacities are unmatched in 
the microbial world. We should do our best to harness 
their abilities! Fundamental and applied science on fungi 
offers solutions for the shift from our current petroleum-
based economy into a bio-based circular economy, opens 
new avenues for food security as demand increases from 
a growing human population, and provides us with new 
concepts on how to ensure human, animal and plant 
health in the future. Science on fungi discussed in this 
white paper already contributes to 10 out of 17 UN devel-
opment goals (Fig.  8) and their role will become even 
more important for the future of mankind.
The economist Peter Drucker (1909–2005) once 
said: “The best way to predict your future is to create 
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it.” Stronger mutual collaborations between scientists, 
engineers, artists, designers and industrial stakehold-
ers, and vivid communication with the general public 
and policymakers will ensure that the inter- and trans-
disciplinary science on fungi will create a path towards 
innovative breakthroughs. As Peter Drucker suggests, 
this will create a sustainable economic future based on 
fungal cell factories for years to come.
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